Publications by authors named "Jia-Lun Han"
Front Pharmacol
January 2021
Article Synopsis
- * The study involved 1,361 adult patients undergoing percutaneous coronary intervention, where those with a LOF allele were more likely to be given ticagrelor instead of clopidogrel to improve outcomes.
- * Results showed that patients with a LOF allele on clopidogrel had a higher rate of major adverse events (MACCE) compared to those on ticagrelor, indicating a potential benefit from personalized medication strategies based on genetic testing.
